Hospital for Special Surgery announces leadership changes in neurology, anesthesiology
Click Here to Manage Email Alerts
Key takeaways:
- Lan Zhou, MD, PhD, has been appointed neurologist-in-chief at Hospital for Special Surgery.
- Stavros G. Memtsoudis, MD, PhD, MBA, has been appointed anesthesiologist-in-chief at Hospital for Special Surgery.
Hospital for Special Surgery has appointed Lan Zhou, MD, PhD, as neurologist-in-chief and Stavros G. Memtsoudis, MD, PhD, MBA, as anesthesiologist-in-chief, according to a press release.
In addition to being neurologist-in-chief, Zhou has also been appointed chair of the Marcia Dunn and Jonathan Sobel Department of Neurology at Hospital for Special Surgery (HSS). Zhou is a neuromuscular specialist who earned her medical degree from Shanghai Medical University School of Medicine in China and her PhD in developmental biology at the University of Cincinnati College of Medicine. She will succeed Matthew E. Fink, MD, effective March 1, 2024.
“I’m honored to take on this new role, building upon and developing new programs that will continue to serve the diverse patient communities at HSS,” Zhou said in the release. “My passion is to make a meaningful impact in the lives of patients and families living with neuromuscular diseases and to work with musculoskeletal teams to develop effective treatments to help them live better,” she added.
In addition to being anesthesiologist-in-chief, Memtsoudis has also been appointed as chair of the Marcia Dunn and Jonathan Sobel Department of Neurology at HSS. Memtsoudis is a board-certified anesthesiologist and critical care physician who earned his medical degree and PhD from Georg-August-University Medical School Germany and his MBA from the University of Massachusetts. He succeeds Gregory A. Liguori, MD, effective immediately.
“Excellence and continuity of patient care are our highest priorities at HSS,” Memtsoudis said in the release. “I have the pleasure of being a member of an incredible team of experts, and I’m equally passionate about working alongside internationally prominent clinician-scientists who prioritize delivering the highest-quality care to all our patients,” he added.